NCT05402059
Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice No drug interventions Not Available Not Available recruiting NCT05169957
Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) treatment 1 active_not_recruiting NCT02678572
Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma treatment 3 completed NCT01728051
Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver Not Available Not Available no_longer_available NCT00351728
Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone No drug interventions Not Available Not Available completed NCT03172299
Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated With Proton Therapy for a Large Choroidal Melanoma treatment 3 recruiting NCT02909517
The Role of Inflammation in Ocular Tumours No drug interventions Not Available Not Available unknown_status NCT00621439
Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye basic_science Not Available withdrawn NCT04364230
Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma) No drug interventions treatment 1 / 2 completed NCT04417530
Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma treatment 2 completed NCT01355120
THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease treatment 2 completed NCT03052127
Study in Subjects With Small Primary Choroidal Melanoma treatment 1 / 2 completed NCT00346372
Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy No drug interventions Not Available Not Available terminated NCT03528408
Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma treatment 2 active_not_recruiting NCT05187884
Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma treatment 2 active_not_recruiting NCT05628883
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma treatment 1 recruiting NCT02129075
A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma treatment 2 completed NCT00168870
Study of Metastatic Ocular Melanoma treatment 2 unknown_status NCT01893099
Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma treatment 1 completed NCT05524935
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma treatment 2 recruiting NCT02519322
Neoadjuvant and Adjuvant Checkpoint Blockade treatment 2 completed NCT06432660
Eye Plaque Brachytherapy for Ocular Melanoma No drug interventions Not Available Not Available recruiting NCT01930968
Definity for Ultrasound of Intraocular Tumors No drug interventions Not Available Not Available withdrawn NCT02858869
Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases treatment 1 completed NCT01200238
STA-9090(Ganetespib) in Metastatic Ocular Melanoma treatment 2 completed NCT06007690
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma treatment 3 recruiting